Is AI Revolutionizing Outsourced Drug Manufacturing?
Source: Outsourced Pharma
By Jeffrey S. Buguliskis, PhD, Deputy Chief Editor, Outsourced Pharma
Is AI REALLY revolutionizing outsourced drug manufacturing, or are we still sorting useful tools from industry hype? In this episode of The Outsourcing Advisor, Bikash Chatterjee, President and Chief Science Officer of Pharmatech Associates and a member of the Outsourced Pharma Editorial Board, joins us for a fast-paced game of “AI Hype, Help, or Hazard?” He puts real-world use cases to the test, from CDMO selection and tech transfer to manufacturing, regulatory work, supply chain decisions, and partner oversight, to see where AI is delivering value today and where sponsors should still proceed with caution.